GSK plc Interest Expense Income Net Defined Benefit Liability Asset
GSK plc (GLAXF) reported Interest Expense Income Net Defined Benefit Liability Asset of -GBP 4.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-06.
Financial Statements › Expense Statement › Interest Expense
ifrs-full:InterestExpenseIncomeNetDefinedBenefitLiabilityAsset · last filed 2026-03-06
| Period end | Interest Expense Income Net Defined Benefit Liability Asset 12 month |
|---|---|
| 2025-12-31 | -4.00M GBP 20-F · filed 2026-03-06 |
| 2024-12-31 | 25.00M GBP 20-F · filed 2026-03-06 |
| 2023-12-31 | 45.00M GBP 20-F · filed 2026-03-06 |
| 2022-12-31 | 18.00M GBP 20-F · filed 2025-03-03 |
| 2021-12-31 | 27.00M GBP 20-F · filed 2024-03-05 |
| 2020-12-31 | 36.00M GBP 20-F · filed 2023-03-10 |
| 2019-12-31 | 26.00M GBP 20-F · filed 2022-03-08 |
| 2018-12-31 | 36.00M GBP 20-F · filed 2021-03-12 |
| 2017-12-31 | 54.00M GBP 20-F · filed 2020-03-06 |
| 2016-12-31 | 56.00M GBP 20-F · filed 2019-03-15 |
| 2015-12-31 | 49.00M GBP 20-F/A · filed 2018-03-20 |